Researchers at the University of Rochester Medical Center in New York say abandoning PSA tests could triple the number of patients developing advanced cancer
In May, the US Preventative Services Task Force advised against routine PSA screenings saying they lead to overly aggressive treatment of non-lethal cancers and unnecessarily subject patients to serious side effects.
The new study's authors say despite some drawbacks, PSA testing remains the best option for early detection and hence- patient survival. Their findings are presented in today's journal Cancer.
